Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 3 studies | 49% ± 21% |
Insufficient scRNA-seq data for expression of FRRS1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 637.12 | 226 / 226 | 97% | 13.88 | 393 / 406 |
breast | 99% | 233.49 | 456 / 459 | 92% | 5.69 | 1028 / 1118 |
uterus | 99% | 192.65 | 169 / 170 | 91% | 10.35 | 417 / 459 |
lung | 99% | 216.29 | 570 / 578 | 90% | 8.76 | 1045 / 1155 |
esophagus | 90% | 359.91 | 1298 / 1445 | 97% | 10.42 | 177 / 183 |
ovary | 100% | 237.97 | 180 / 180 | 86% | 3.87 | 370 / 430 |
prostate | 91% | 134.74 | 223 / 245 | 91% | 3.88 | 457 / 502 |
bladder | 90% | 200.95 | 19 / 21 | 90% | 9.87 | 456 / 504 |
thymus | 99% | 216.23 | 649 / 653 | 79% | 3.20 | 475 / 605 |
stomach | 94% | 242.40 | 339 / 359 | 76% | 4.07 | 217 / 286 |
skin | 100% | 536.17 | 1804 / 1809 | 64% | 3.08 | 302 / 472 |
pancreas | 68% | 63.57 | 222 / 328 | 91% | 7.56 | 162 / 178 |
intestine | 82% | 158.92 | 791 / 966 | 75% | 3.65 | 394 / 527 |
kidney | 65% | 67.42 | 58 / 89 | 79% | 4.59 | 713 / 901 |
adrenal gland | 98% | 418.19 | 253 / 258 | 22% | 1.17 | 51 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.39 | 1 / 1 |
adipose | 98% | 217.91 | 1184 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 17.87 | 43 / 45 |
blood vessel | 93% | 145.44 | 1240 / 1335 | 0% | 0 | 0 / 0 |
heart | 85% | 125.90 | 734 / 861 | 0% | 0 | 0 / 0 |
spleen | 77% | 77.52 | 185 / 241 | 0% | 0 | 0 / 0 |
muscle | 67% | 72.10 | 536 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 45% | 1.41 | 13 / 29 |
peripheral blood | 31% | 132.79 | 288 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 23% | 0.63 | 18 / 80 |
brain | 2% | 2.10 | 55 / 2642 | 15% | 0.47 | 107 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006879 | Biological process | intracellular iron ion homeostasis |
GO_0016020 | Cellular component | membrane |
GO_0046872 | Molecular function | metal ion binding |
GO_0016722 | Molecular function | oxidoreductase activity, acting on metal ions |
Gene name | FRRS1 |
Protein name | Ferric-chelate reductase 1 (EC 1.-.-.-) (Stromal cell-derived receptor 2) (SDR-2) |
Synonyms | SDR2 SDFR2 |
Description | FUNCTION: Ferric-chelate reductases reduce Fe(3+) to Fe(2+) before its transport from the endosome to the cytoplasm. . |
Accessions | ENST00000287474.9 [Q6ZNA5-2] ENST00000646001.2 [Q6ZNA5-1] Q6ZNA5 |